Evercore analyst Vijay Kumar maintains $Baxter International Inc (BAX.US)$ with a buy rating, and maintains the target price at $45.
According to TipRanks data, the analyst has a success rate of 54.8% and a total average return of 4.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Baxter International Inc (BAX.US)$'s main analysts recently are as follows:
Baxter's recent quarterly earnings report showcased sales figures that met expectations, alongside EPS that exceeded predictions. Nevertheless, the company's performance in the third quarter and subsequent discussions revealed complexities, notably stemming from hurricane-induced disruptions at the North Cove manufacturing facility. Such events in late Q3 have significantly influenced the fourth quarter, resulting in sales and EPS forecasts that fall short of previous consensus. Despite these challenges, there is a substantial degree of optimism about the company's growth potential, specifically anticipating operational sales growth of 4%-5% year-over-year and targeting an adjusted operating margin of 16.5% by 2025 for the RemainCo business excluding the Kidney division.
Post-earnings, it is believed that clarifying the impact of stranded costs will bolster confidence in Baxter's capability to achieve its operating margin goal. It is also thought that there is a measure of caution factored into the financial projections for the coming years.
The firm expressed that Baxter remains optimistic about its outlook for 2025, with expectations of 4%-5% operational sales growth and a 16.5% operating margin. The firm's calculations suggest that the 2025 earnings per share for RemainCo could be $2.52.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
Evercore分析師Vijay Kumar維持$百特國際 (BAX.US)$買入評級，維持目標價45美元。
根據TipRanks數據顯示，該分析師近一年總勝率為54.8%，總平均回報率為4.2%。
此外，綜合報道，$百特國際 (BAX.US)$近期主要分析師觀點如下：
百特最近的季度收益報告顯示了符合預期的銷售數據，每股收益也超出了預期。儘管如此，該公司第三季度的業績和隨後的討論揭示了複雜性，主要是颶風導致的北灣製造工廠中斷。第三季度末的此類事件對第四季度產生了重大影響，導致銷售額和每股收益預測低於先前的共識。儘管面臨這些挑戰，但人們對公司的增長潛力仍相當樂觀，特別是預計運營銷售額同比增長4％-5％，目標是到2025年將ReminCo業務（不包括腎臟部門）的調整後營業利潤率達到16.5％。
業績公佈後，據信，澄清擱淺成本的影響將增強人們對百特實現其營業利潤率目標的能力的信心。還有人認爲，在未來幾年的財務預測中有一定程度的謹慎考慮。
該公司表示，百特對2025年的前景仍然樂觀，預計營業銷售增長4％-5％，營業利潤率爲16.5％。該公司的計算表明，RemainCo2025年的每股收益可能爲2.52美元。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
